Details for Patent: 7,662,407
✉ Email this page to a colleague
Title: | Modified release formulations of a bupropion salt |
Abstract: | The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition. |
Inventor(s): | Oberegger; Werner (Mississauga, CA), Maes; Paul (Toronto, CA), Jackson; Graham (Co. Kildare, IE), Saleh; Mohammad Ashty (Oakville, CA) |
Assignee: | Biovail Laboratories International S.R.L. (St. Michael, BB) |
Filing Date: | Jun 21, 2007 |
Application Number: | 11/766,251 |
Claims: | 1. A controlled release composition comprising: a core comprising a therapeutically effective amount of bupropion hydrobromide; and a controlled release polymeric coat comprising a water-insoluble polymer and a water-soluble polymer. 2. A controlled release composition comprising: a therapeutically effective amount of bupropion hydrobromide; and a controlled release polymeric coat comprising a water-insoluble polymer, a water-soluble polymer, and a plasticizer. 3. The controlled release composition of claim 2, wherein the ratio of water-insoluble polymer:plasticizer:water-soluble polymer is from about 3:1:4 to about 5:1:2. 4. The controlled release composition of claim 2, wherein the water-insoluble polymer is ethylcellulose; the water-soluble polymer is selected from the group consisting of polyvinylpyrrolidone, hydroxypropyl methylcellulose, hydroxypropyl cellulose, and mixtures thereof; and the plasticizer is selected from the group consisting of dibutyl sebacate, polyethylene glycol 4000, and mixtures thereof. 5. A controlled release composition comprising: a core comprising a therapeutically effective amount of bupropion hydrobromide; and a controlled release polymeric coat. |